Dechra Pharmaceuticals is an international pharmaceutical business based in the United Kingdom. The Company is focused on the veterinary market with its key area of specialization being the development and marketing of companion animal products. The Company operates the following two divisions: Pharmaceuticals and Services. The Pharmaceuticals Division develops, markets and sells veterinary pharmaceuticals and specialist pet diets into international companion animal markets. Additionally, the Pharmaceuticals Division manufactures the Company's own branded pharmaceutical products and manufactures both veterinary and human pharmaceuticals on a contract basis for third parties.
Data provided by Mergent, Inc.
Powered by Interactive Data Managed Solutions
Powered by Regulatory News Service
Data provided by Thomson Reuters, Inc.
| DR Symbol | DPHAY |
| CUSIP | 243435104 |
| DR Exchange | OTC |
| DR ISIN | US2434351043 |
| Ratio DR:ORD | 1:2 |
| Depositary | BK (Unsponsored) |
| First Filer | BK |
| Effective Date | May 08, 2012 |
| Underlying ISIN | GB0009633180 |
| Underlying SEDOL | 0963318 |
| Country | United Kingdom |
| Industry | Pharma. & Biotech. |
| Month |
Month End DR Close Price |
DR Trading Volume |
Avg Day DR Trading Volume |
|---|---|---|---|
May. 13 |
20.74 | n/a | n/a |
Apr. 13 |
22.35 | n/a | n/a |
Mar. 13 |
22.76 | n/a | n/a |
Related linksCustodians / BIC |
Helpful Links |